作者

David Mulder

高级律师

Read More

Christian Dekoninck

合伙人

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

Dr Paul England

Senior Counsel – Knowledge

Read More
作者

David Mulder

高级律师

Read More

Christian Dekoninck

合伙人

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

Dr Paul England

Senior Counsel – Knowledge

Read More

2020年11月9日

Pharmaceutical patent law – 1 / 2 观点

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

  • Quick read

What is the role of patent law in emergency situations like the current coronavirus pandemic? And what exceptions to the law are there under such circumstances?

In the first article of our two-part series written for the European Intellectual Property Review, our international team consider these questions and more on both a broad, European level and from the perspective of six national jurisdictions.

Read the article here

本系列内容

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

酒店与休闲

Three hot IP issues for the pharmaceutical industry

2022年8月23日
Briefing

作者 Dr Paul England

点击此处了解更多
UPC

It is time to think about UPC opt-out again: what opt-out does

Part 1

2022年1月17日
In-depth analysis

作者

点击此处了解更多
UPC

It is time to think about UPC opt-out again: how it is achieved and its strategic implications

Part 2

2022年1月17日
In-depth analysis

作者

点击此处了解更多